There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Chemical Works of Gedeon Richter (RGEDF – Research Report) and Dexcom (DXCM – Research Report) with bullish sentiments.
Discover the Best Stocks and Maximize Your Portfolio:
Chemical Works of Gedeon Richter (RGEDF)
In a report issued on March 7, James Vane from Jefferies maintained a Buy rating on Chemical Works of Gedeon Richter, with a price target of Ft12594.00. The company’s shares closed last Friday at $27.17.
Vane has an average return of 12.9% when recommending Chemical Works of Gedeon Richter.
According to TipRanks.com, Vane is ranked #8766 out of 9418 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Chemical Works of Gedeon Richter with a $34.19 average price target.
See the top stocks recommended by analysts >>
Dexcom (DXCM)
In a report issued on March 7, Travis Steed from Bank of America Securities maintained a Buy rating on Dexcom, with a price target of $105.00. The company’s shares closed last Friday at $77.84.
According to TipRanks.com, Steed is a 5-star analyst with an average return of 10.1% and a 61.5% success rate. Steed covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Zimmer Biomet Holdings, and Edwards Lifesciences.
Dexcom has an analyst consensus of Strong Buy, with a price target consensus of $102.71, representing a 29.2% upside. In a report issued on March 4, Citi also maintained a Buy rating on the stock with a $104.00 price target.
Read More on RGEDF: